Gilead's Biktarvy wins megablockbuster HIV nod, and rival GlaxoSmithKline strikes back | Fierce Pharma
Gilead Advancing Access®: What to Know | Prism Health North Texas
Gilead Will Donate Truvada to U.S. for H.I.V. Prevention - The New York Times
FDA approves Gilead's multi-drug resistant HIV-1 treatment
Gilead drug remdesivir shows promise in two coronavirus trials
United States v. Gilead: The Fight for PrEP | Bill of Health
Gilead Revenue Soars on Hepatitis C Drug - The New York Times
Generic HIV prevention drug coming in 2020, Gilead says
PrEP's Still Too Costly For Many People At Risk For HIV : Shots - Health News : NPR
Single patient study adds to debate over Gilead's remdesivir for COVID-19 | Reuters
Top Research Reports for JPMorgan, Gilead Sciences & CSX
Trump administration sues Gilead over HIV drugs
Gilead says counterfeiters sold $250M worth of fake HIV drugs, sues distributors | Fierce Pharma
Gilead to Slice List Prices of Liver Drugs - WSJ
Gilead bags EU approval for next-generation HIV drug - PMLiVE
Gilead Sciences, Inc.
New Data On Gilead's Covid-19 Drug Is Positive, but Inconclusive | Barron's
Change to Gilead assistance program threatens PrEP access, HIV advocates say | PBS NewsHour
Gilead to donate HIV prevention drug Truvada to 200K uninsured patients
Gilead Wins Key Patent Rights Suit Over PrEP Drugs for Preventing HIV - The New York Times
Pharma giant Gilead sued for 'withholding' safer HIV drug | PinkNews
Gilead Revenue Soars on Hepatitis C Drug - The New York Times
